Description
ABVIDA SR 100 Tablet is a sustained-release formulation of Vildagliptin for type 2 diabetes management. This DPP-4 inhibitor helps control blood glucose levels by increasing incretin hormone levels. The extended-release design provides once-daily dosing convenience for patients requiring glycemic control. The product is available in sustained-release tablet form for oral administration. Use the product according to the instructions provided on the packaging or as advised by a healthcare professional. Please read the product label carefully and follow all recommended precautions and warnings before using this medicine. Important Note: This information is for general product purposes only and is not intended as medical advice. Always consult a healthcare professional before use.
Reviews
There are no reviews yet.